Global Long-acting GLP-1RA Market Research Report 2024, Forecast to 2032
Report Overview
A long-acting GLP-1RA, or Long-acting Glucagon-Like Peptide-1 Receptor Agonist, is a medication designed for the treatment of type 2 diabetes and, in some cases, obesity. It is characterized by an extended half-life, typically requiring only once-weekly injections. Long-acting GLP-1RAs have the ability to enhance insulin secretion from the pancreas and reduce the release of glucagon, thereby lowering post-meal blood sugar levels. Furthermore, they are effective at reducing fasting blood sugar levels and have a more pronounced effect on weight loss.
The global Long-acting GLP-1RA market size was estimated at USD 17600 million in 2023 and is projected to reach USD 33743.40 million by 2032, exhibiting a CAGR of 7.50% during the forecast period.
North America Long-acting GLP-1RA market size was estimated at USD 5194.65 million in 2023, at a CAGR of 6.43% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global Long-acting GLP-1RA market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Long-acting GLP-1RA Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Long-acting GLP-1RA market in any manner.
Global Long-acting GLP-1RA Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Novo Nordisk
GSK
Novo Nordisk
AstraZeneca
Eli Lily
Hansoh Pharmaceutical
Market Segmentation (by Type)
Liraglutide
Albiglutide
Dulaglutide
Semaglutide
Polyethylene Glycol Loxenatide
Exenatide Microspheres
Market Segmentation (by Application)
Hospital
Clinic
Other
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Long-acting GLP-1RA Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Long-acting GLP-1RA, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
A long-acting GLP-1RA, or Long-acting Glucagon-Like Peptide-1 Receptor Agonist, is a medication designed for the treatment of type 2 diabetes and, in some cases, obesity. It is characterized by an extended half-life, typically requiring only once-weekly injections. Long-acting GLP-1RAs have the ability to enhance insulin secretion from the pancreas and reduce the release of glucagon, thereby lowering post-meal blood sugar levels. Furthermore, they are effective at reducing fasting blood sugar levels and have a more pronounced effect on weight loss.
The global Long-acting GLP-1RA market size was estimated at USD 17600 million in 2023 and is projected to reach USD 33743.40 million by 2032, exhibiting a CAGR of 7.50% during the forecast period.
North America Long-acting GLP-1RA market size was estimated at USD 5194.65 million in 2023, at a CAGR of 6.43% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global Long-acting GLP-1RA market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Long-acting GLP-1RA Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Long-acting GLP-1RA market in any manner.
Global Long-acting GLP-1RA Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Novo Nordisk
GSK
Novo Nordisk
AstraZeneca
Eli Lily
Hansoh Pharmaceutical
Market Segmentation (by Type)
Liraglutide
Albiglutide
Dulaglutide
Semaglutide
Polyethylene Glycol Loxenatide
Exenatide Microspheres
Market Segmentation (by Application)
Hospital
Clinic
Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Long-acting GLP-1RA Market
- Overview of the regional outlook of the Long-acting GLP-1RA Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Long-acting GLP-1RA Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Long-acting GLP-1RA, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Long-acting GLP-1RA
1.2 Key Market Segments
1.2.1 Long-acting GLP-1RA Segment by Type
1.2.2 Long-acting GLP-1RA Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 LONG-ACTING GLP-1RA MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Long-acting GLP-1RA Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Long-acting GLP-1RA Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 LONG-ACTING GLP-1RA MARKET COMPETITIVE LANDSCAPE
3.1 Global Long-acting GLP-1RA Sales by Manufacturers (2019-2024)
3.2 Global Long-acting GLP-1RA Revenue Market Share by Manufacturers (2019-2024)
3.3 Long-acting GLP-1RA Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Long-acting GLP-1RA Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Long-acting GLP-1RA Sales Sites, Area Served, Product Type
3.6 Long-acting GLP-1RA Market Competitive Situation and Trends
3.6.1 Long-acting GLP-1RA Market Concentration Rate
3.6.2 Global 5 and 10 Largest Long-acting GLP-1RA Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 LONG-ACTING GLP-1RA INDUSTRY CHAIN ANALYSIS
4.1 Long-acting GLP-1RA Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF LONG-ACTING GLP-1RA MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 LONG-ACTING GLP-1RA MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Long-acting GLP-1RA Sales Market Share by Type (2019-2024)
6.3 Global Long-acting GLP-1RA Market Size Market Share by Type (2019-2024)
6.4 Global Long-acting GLP-1RA Price by Type (2019-2024)
7 LONG-ACTING GLP-1RA MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Long-acting GLP-1RA Market Sales by Application (2019-2024)
7.3 Global Long-acting GLP-1RA Market Size (M USD) by Application (2019-2024)
7.4 Global Long-acting GLP-1RA Sales Growth Rate by Application (2019-2024)
8 LONG-ACTING GLP-1RA MARKET CONSUMPTION BY REGION
8.1 Global Long-acting GLP-1RA Sales by Region
8.1.1 Global Long-acting GLP-1RA Sales by Region
8.1.2 Global Long-acting GLP-1RA Sales Market Share by Region
8.2 North America
8.2.1 North America Long-acting GLP-1RA Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Long-acting GLP-1RA Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Long-acting GLP-1RA Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Long-acting GLP-1RA Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Long-acting GLP-1RA Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 LONG-ACTING GLP-1RA MARKET PRODUCTION BY REGION
9.1 Global Production of Long-acting GLP-1RA by Region (2019-2024)
9.2 Global Long-acting GLP-1RA Revenue Market Share by Region (2019-2024)
9.3 Global Long-acting GLP-1RA Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Long-acting GLP-1RA Production
9.4.1 North America Long-acting GLP-1RA Production Growth Rate (2019-2024)
9.4.2 North America Long-acting GLP-1RA Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Long-acting GLP-1RA Production
9.5.1 Europe Long-acting GLP-1RA Production Growth Rate (2019-2024)
9.5.2 Europe Long-acting GLP-1RA Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Long-acting GLP-1RA Production (2019-2024)
9.6.1 Japan Long-acting GLP-1RA Production Growth Rate (2019-2024)
9.6.2 Japan Long-acting GLP-1RA Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Long-acting GLP-1RA Production (2019-2024)
9.7.1 China Long-acting GLP-1RA Production Growth Rate (2019-2024)
9.7.2 China Long-acting GLP-1RA Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 Novo Nordisk
10.1.1 Novo Nordisk Long-acting GLP-1RA Basic Information
10.1.2 Novo Nordisk Long-acting GLP-1RA Product Overview
10.1.3 Novo Nordisk Long-acting GLP-1RA Product Market Performance
10.1.4 Novo Nordisk Business Overview
10.1.5 Novo Nordisk Long-acting GLP-1RA SWOT Analysis
10.1.6 Novo Nordisk Recent Developments
10.2 GSK
10.2.1 GSK Long-acting GLP-1RA Basic Information
10.2.2 GSK Long-acting GLP-1RA Product Overview
10.2.3 GSK Long-acting GLP-1RA Product Market Performance
10.2.4 GSK Business Overview
10.2.5 GSK Long-acting GLP-1RA SWOT Analysis
10.2.6 GSK Recent Developments
10.3 Novo Nordisk
10.3.1 Novo Nordisk Long-acting GLP-1RA Basic Information
10.3.2 Novo Nordisk Long-acting GLP-1RA Product Overview
10.3.3 Novo Nordisk Long-acting GLP-1RA Product Market Performance
10.3.4 Novo Nordisk Long-acting GLP-1RA SWOT Analysis
10.3.5 Novo Nordisk Business Overview
10.3.6 Novo Nordisk Recent Developments
10.4 AstraZeneca
10.4.1 AstraZeneca Long-acting GLP-1RA Basic Information
10.4.2 AstraZeneca Long-acting GLP-1RA Product Overview
10.4.3 AstraZeneca Long-acting GLP-1RA Product Market Performance
10.4.4 AstraZeneca Business Overview
10.4.5 AstraZeneca Recent Developments
10.5 Eli Lily
10.5.1 Eli Lily Long-acting GLP-1RA Basic Information
10.5.2 Eli Lily Long-acting GLP-1RA Product Overview
10.5.3 Eli Lily Long-acting GLP-1RA Product Market Performance
10.5.4 Eli Lily Business Overview
10.5.5 Eli Lily Recent Developments
10.6 Hansoh Pharmaceutical
10.6.1 Hansoh Pharmaceutical Long-acting GLP-1RA Basic Information
10.6.2 Hansoh Pharmaceutical Long-acting GLP-1RA Product Overview
10.6.3 Hansoh Pharmaceutical Long-acting GLP-1RA Product Market Performance
10.6.4 Hansoh Pharmaceutical Business Overview
10.6.5 Hansoh Pharmaceutical Recent Developments
11 LONG-ACTING GLP-1RA MARKET FORECAST BY REGION
11.1 Global Long-acting GLP-1RA Market Size Forecast
11.2 Global Long-acting GLP-1RA Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Long-acting GLP-1RA Market Size Forecast by Country
11.2.3 Asia Pacific Long-acting GLP-1RA Market Size Forecast by Region
11.2.4 South America Long-acting GLP-1RA Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Long-acting GLP-1RA by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Long-acting GLP-1RA Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Long-acting GLP-1RA by Type (2025-2032)
12.1.2 Global Long-acting GLP-1RA Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Long-acting GLP-1RA by Type (2025-2032)
12.2 Global Long-acting GLP-1RA Market Forecast by Application (2025-2032)
12.2.1 Global Long-acting GLP-1RA Sales (K MT) Forecast by Application
12.2.2 Global Long-acting GLP-1RA Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Long-acting GLP-1RA
1.2 Key Market Segments
1.2.1 Long-acting GLP-1RA Segment by Type
1.2.2 Long-acting GLP-1RA Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 LONG-ACTING GLP-1RA MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Long-acting GLP-1RA Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Long-acting GLP-1RA Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 LONG-ACTING GLP-1RA MARKET COMPETITIVE LANDSCAPE
3.1 Global Long-acting GLP-1RA Sales by Manufacturers (2019-2024)
3.2 Global Long-acting GLP-1RA Revenue Market Share by Manufacturers (2019-2024)
3.3 Long-acting GLP-1RA Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Long-acting GLP-1RA Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Long-acting GLP-1RA Sales Sites, Area Served, Product Type
3.6 Long-acting GLP-1RA Market Competitive Situation and Trends
3.6.1 Long-acting GLP-1RA Market Concentration Rate
3.6.2 Global 5 and 10 Largest Long-acting GLP-1RA Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 LONG-ACTING GLP-1RA INDUSTRY CHAIN ANALYSIS
4.1 Long-acting GLP-1RA Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF LONG-ACTING GLP-1RA MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 LONG-ACTING GLP-1RA MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Long-acting GLP-1RA Sales Market Share by Type (2019-2024)
6.3 Global Long-acting GLP-1RA Market Size Market Share by Type (2019-2024)
6.4 Global Long-acting GLP-1RA Price by Type (2019-2024)
7 LONG-ACTING GLP-1RA MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Long-acting GLP-1RA Market Sales by Application (2019-2024)
7.3 Global Long-acting GLP-1RA Market Size (M USD) by Application (2019-2024)
7.4 Global Long-acting GLP-1RA Sales Growth Rate by Application (2019-2024)
8 LONG-ACTING GLP-1RA MARKET CONSUMPTION BY REGION
8.1 Global Long-acting GLP-1RA Sales by Region
8.1.1 Global Long-acting GLP-1RA Sales by Region
8.1.2 Global Long-acting GLP-1RA Sales Market Share by Region
8.2 North America
8.2.1 North America Long-acting GLP-1RA Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Long-acting GLP-1RA Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Long-acting GLP-1RA Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Long-acting GLP-1RA Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Long-acting GLP-1RA Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 LONG-ACTING GLP-1RA MARKET PRODUCTION BY REGION
9.1 Global Production of Long-acting GLP-1RA by Region (2019-2024)
9.2 Global Long-acting GLP-1RA Revenue Market Share by Region (2019-2024)
9.3 Global Long-acting GLP-1RA Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Long-acting GLP-1RA Production
9.4.1 North America Long-acting GLP-1RA Production Growth Rate (2019-2024)
9.4.2 North America Long-acting GLP-1RA Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Long-acting GLP-1RA Production
9.5.1 Europe Long-acting GLP-1RA Production Growth Rate (2019-2024)
9.5.2 Europe Long-acting GLP-1RA Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Long-acting GLP-1RA Production (2019-2024)
9.6.1 Japan Long-acting GLP-1RA Production Growth Rate (2019-2024)
9.6.2 Japan Long-acting GLP-1RA Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Long-acting GLP-1RA Production (2019-2024)
9.7.1 China Long-acting GLP-1RA Production Growth Rate (2019-2024)
9.7.2 China Long-acting GLP-1RA Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 Novo Nordisk
10.1.1 Novo Nordisk Long-acting GLP-1RA Basic Information
10.1.2 Novo Nordisk Long-acting GLP-1RA Product Overview
10.1.3 Novo Nordisk Long-acting GLP-1RA Product Market Performance
10.1.4 Novo Nordisk Business Overview
10.1.5 Novo Nordisk Long-acting GLP-1RA SWOT Analysis
10.1.6 Novo Nordisk Recent Developments
10.2 GSK
10.2.1 GSK Long-acting GLP-1RA Basic Information
10.2.2 GSK Long-acting GLP-1RA Product Overview
10.2.3 GSK Long-acting GLP-1RA Product Market Performance
10.2.4 GSK Business Overview
10.2.5 GSK Long-acting GLP-1RA SWOT Analysis
10.2.6 GSK Recent Developments
10.3 Novo Nordisk
10.3.1 Novo Nordisk Long-acting GLP-1RA Basic Information
10.3.2 Novo Nordisk Long-acting GLP-1RA Product Overview
10.3.3 Novo Nordisk Long-acting GLP-1RA Product Market Performance
10.3.4 Novo Nordisk Long-acting GLP-1RA SWOT Analysis
10.3.5 Novo Nordisk Business Overview
10.3.6 Novo Nordisk Recent Developments
10.4 AstraZeneca
10.4.1 AstraZeneca Long-acting GLP-1RA Basic Information
10.4.2 AstraZeneca Long-acting GLP-1RA Product Overview
10.4.3 AstraZeneca Long-acting GLP-1RA Product Market Performance
10.4.4 AstraZeneca Business Overview
10.4.5 AstraZeneca Recent Developments
10.5 Eli Lily
10.5.1 Eli Lily Long-acting GLP-1RA Basic Information
10.5.2 Eli Lily Long-acting GLP-1RA Product Overview
10.5.3 Eli Lily Long-acting GLP-1RA Product Market Performance
10.5.4 Eli Lily Business Overview
10.5.5 Eli Lily Recent Developments
10.6 Hansoh Pharmaceutical
10.6.1 Hansoh Pharmaceutical Long-acting GLP-1RA Basic Information
10.6.2 Hansoh Pharmaceutical Long-acting GLP-1RA Product Overview
10.6.3 Hansoh Pharmaceutical Long-acting GLP-1RA Product Market Performance
10.6.4 Hansoh Pharmaceutical Business Overview
10.6.5 Hansoh Pharmaceutical Recent Developments
11 LONG-ACTING GLP-1RA MARKET FORECAST BY REGION
11.1 Global Long-acting GLP-1RA Market Size Forecast
11.2 Global Long-acting GLP-1RA Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Long-acting GLP-1RA Market Size Forecast by Country
11.2.3 Asia Pacific Long-acting GLP-1RA Market Size Forecast by Region
11.2.4 South America Long-acting GLP-1RA Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Long-acting GLP-1RA by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Long-acting GLP-1RA Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Long-acting GLP-1RA by Type (2025-2032)
12.1.2 Global Long-acting GLP-1RA Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Long-acting GLP-1RA by Type (2025-2032)
12.2 Global Long-acting GLP-1RA Market Forecast by Application (2025-2032)
12.2.1 Global Long-acting GLP-1RA Sales (K MT) Forecast by Application
12.2.2 Global Long-acting GLP-1RA Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Long-acting GLP-1RA Market Size Comparison by Region (M USD)
Table 5. Global Long-acting GLP-1RA Sales (K MT) by Manufacturers (2019-2024)
Table 6. Global Long-acting GLP-1RA Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Long-acting GLP-1RA Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Long-acting GLP-1RA Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long-acting GLP-1RA as of 2022)
Table 10. Global Market Long-acting GLP-1RA Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Long-acting GLP-1RA Sales Sites and Area Served
Table 12. Manufacturers Long-acting GLP-1RA Product Type
Table 13. Global Long-acting GLP-1RA Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Long-acting GLP-1RA
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Long-acting GLP-1RA Market Challenges
Table 22. Global Long-acting GLP-1RA Sales by Type (K MT)
Table 23. Global Long-acting GLP-1RA Market Size by Type (M USD)
Table 24. Global Long-acting GLP-1RA Sales (K MT) by Type (2019-2024)
Table 25. Global Long-acting GLP-1RA Sales Market Share by Type (2019-2024)
Table 26. Global Long-acting GLP-1RA Market Size (M USD) by Type (2019-2024)
Table 27. Global Long-acting GLP-1RA Market Size Share by Type (2019-2024)
Table 28. Global Long-acting GLP-1RA Price (USD/MT) by Type (2019-2024)
Table 29. Global Long-acting GLP-1RA Sales (K MT) by Application
Table 30. Global Long-acting GLP-1RA Market Size by Application
Table 31. Global Long-acting GLP-1RA Sales by Application (2019-2024) & (K MT)
Table 32. Global Long-acting GLP-1RA Sales Market Share by Application (2019-2024)
Table 33. Global Long-acting GLP-1RA Sales by Application (2019-2024) & (M USD)
Table 34. Global Long-acting GLP-1RA Market Share by Application (2019-2024)
Table 35. Global Long-acting GLP-1RA Sales Growth Rate by Application (2019-2024)
Table 36. Global Long-acting GLP-1RA Sales by Region (2019-2024) & (K MT)
Table 37. Global Long-acting GLP-1RA Sales Market Share by Region (2019-2024)
Table 38. North America Long-acting GLP-1RA Sales by Country (2019-2024) & (K MT)
Table 39. Europe Long-acting GLP-1RA Sales by Country (2019-2024) & (K MT)
Table 40. Asia Pacific Long-acting GLP-1RA Sales by Region (2019-2024) & (K MT)
Table 41. South America Long-acting GLP-1RA Sales by Country (2019-2024) & (K MT)
Table 42. Middle East and Africa Long-acting GLP-1RA Sales by Region (2019-2024) & (K MT)
Table 43. Global Long-acting GLP-1RA Production (K MT) by Region (2019-2024)
Table 44. Global Long-acting GLP-1RA Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Long-acting GLP-1RA Revenue Market Share by Region (2019-2024)
Table 46. Global Long-acting GLP-1RA Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 47. North America Long-acting GLP-1RA Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 48. Europe Long-acting GLP-1RA Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 49. Japan Long-acting GLP-1RA Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 50. China Long-acting GLP-1RA Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 51. Novo Nordisk Long-acting GLP-1RA Basic Information
Table 52. Novo Nordisk Long-acting GLP-1RA Product Overview
Table 53. Novo Nordisk Long-acting GLP-1RA Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 54. Novo Nordisk Business Overview
Table 55. Novo Nordisk Long-acting GLP-1RA SWOT Analysis
Table 56. Novo Nordisk Recent Developments
Table 57. GSK Long-acting GLP-1RA Basic Information
Table 58. GSK Long-acting GLP-1RA Product Overview
Table 59. GSK Long-acting GLP-1RA Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 60. GSK Business Overview
Table 61. GSK Long-acting GLP-1RA SWOT Analysis
Table 62. GSK Recent Developments
Table 63. Novo Nordisk Long-acting GLP-1RA Basic Information
Table 64. Novo Nordisk Long-acting GLP-1RA Product Overview
Table 65. Novo Nordisk Long-acting GLP-1RA Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 66. Novo Nordisk Long-acting GLP-1RA SWOT Analysis
Table 67. Novo Nordisk Business Overview
Table 68. Novo Nordisk Recent Developments
Table 69. AstraZeneca Long-acting GLP-1RA Basic Information
Table 70. AstraZeneca Long-acting GLP-1RA Product Overview
Table 71. AstraZeneca Long-acting GLP-1RA Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 72. AstraZeneca Business Overview
Table 73. AstraZeneca Recent Developments
Table 74. Eli Lily Long-acting GLP-1RA Basic Information
Table 75. Eli Lily Long-acting GLP-1RA Product Overview
Table 76. Eli Lily Long-acting GLP-1RA Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 77. Eli Lily Business Overview
Table 78. Eli Lily Recent Developments
Table 79. Hansoh Pharmaceutical Long-acting GLP-1RA Basic Information
Table 80. Hansoh Pharmaceutical Long-acting GLP-1RA Product Overview
Table 81. Hansoh Pharmaceutical Long-acting GLP-1RA Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 82. Hansoh Pharmaceutical Business Overview
Table 83. Hansoh Pharmaceutical Recent Developments
Table 84. Global Long-acting GLP-1RA Sales Forecast by Region (2025-2032) & (K MT)
Table 85. Global Long-acting GLP-1RA Market Size Forecast by Region (2025-2032) & (M USD)
Table 86. North America Long-acting GLP-1RA Sales Forecast by Country (2025-2032) & (K MT)
Table 87. North America Long-acting GLP-1RA Market Size Forecast by Country (2025-2032) & (M USD)
Table 88. Europe Long-acting GLP-1RA Sales Forecast by Country (2025-2032) & (K MT)
Table 89. Europe Long-acting GLP-1RA Market Size Forecast by Country (2025-2032) & (M USD)
Table 90. Asia Pacific Long-acting GLP-1RA Sales Forecast by Region (2025-2032) & (K MT)
Table 91. Asia Pacific Long-acting GLP-1RA Market Size Forecast by Region (2025-2032) & (M USD)
Table 92. South America Long-acting GLP-1RA Sales Forecast by Country (2025-2032) & (K MT)
Table 93. South America Long-acting GLP-1RA Market Size Forecast by Country (2025-2032) & (M USD)
Table 94. Middle East and Africa Long-acting GLP-1RA Consumption Forecast by Country (2025-2032) & (Units)
Table 95. Middle East and Africa Long-acting GLP-1RA Market Size Forecast by Country (2025-2032) & (M USD)
Table 96. Global Long-acting GLP-1RA Sales Forecast by Type (2025-2032) & (K MT)
Table 97. Global Long-acting GLP-1RA Market Size Forecast by Type (2025-2032) & (M USD)
Table 98. Global Long-acting GLP-1RA Price Forecast by Type (2025-2032) & (USD/MT)
Table 99. Global Long-acting GLP-1RA Sales (K MT) Forecast by Application (2025-2032)
Table 100. Global Long-acting GLP-1RA Market Size Forecast by Application (2025-2032) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Long-acting GLP-1RA Market Size Comparison by Region (M USD)
Table 5. Global Long-acting GLP-1RA Sales (K MT) by Manufacturers (2019-2024)
Table 6. Global Long-acting GLP-1RA Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Long-acting GLP-1RA Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Long-acting GLP-1RA Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long-acting GLP-1RA as of 2022)
Table 10. Global Market Long-acting GLP-1RA Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Long-acting GLP-1RA Sales Sites and Area Served
Table 12. Manufacturers Long-acting GLP-1RA Product Type
Table 13. Global Long-acting GLP-1RA Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Long-acting GLP-1RA
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Long-acting GLP-1RA Market Challenges
Table 22. Global Long-acting GLP-1RA Sales by Type (K MT)
Table 23. Global Long-acting GLP-1RA Market Size by Type (M USD)
Table 24. Global Long-acting GLP-1RA Sales (K MT) by Type (2019-2024)
Table 25. Global Long-acting GLP-1RA Sales Market Share by Type (2019-2024)
Table 26. Global Long-acting GLP-1RA Market Size (M USD) by Type (2019-2024)
Table 27. Global Long-acting GLP-1RA Market Size Share by Type (2019-2024)
Table 28. Global Long-acting GLP-1RA Price (USD/MT) by Type (2019-2024)
Table 29. Global Long-acting GLP-1RA Sales (K MT) by Application
Table 30. Global Long-acting GLP-1RA Market Size by Application
Table 31. Global Long-acting GLP-1RA Sales by Application (2019-2024) & (K MT)
Table 32. Global Long-acting GLP-1RA Sales Market Share by Application (2019-2024)
Table 33. Global Long-acting GLP-1RA Sales by Application (2019-2024) & (M USD)
Table 34. Global Long-acting GLP-1RA Market Share by Application (2019-2024)
Table 35. Global Long-acting GLP-1RA Sales Growth Rate by Application (2019-2024)
Table 36. Global Long-acting GLP-1RA Sales by Region (2019-2024) & (K MT)
Table 37. Global Long-acting GLP-1RA Sales Market Share by Region (2019-2024)
Table 38. North America Long-acting GLP-1RA Sales by Country (2019-2024) & (K MT)
Table 39. Europe Long-acting GLP-1RA Sales by Country (2019-2024) & (K MT)
Table 40. Asia Pacific Long-acting GLP-1RA Sales by Region (2019-2024) & (K MT)
Table 41. South America Long-acting GLP-1RA Sales by Country (2019-2024) & (K MT)
Table 42. Middle East and Africa Long-acting GLP-1RA Sales by Region (2019-2024) & (K MT)
Table 43. Global Long-acting GLP-1RA Production (K MT) by Region (2019-2024)
Table 44. Global Long-acting GLP-1RA Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Long-acting GLP-1RA Revenue Market Share by Region (2019-2024)
Table 46. Global Long-acting GLP-1RA Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 47. North America Long-acting GLP-1RA Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 48. Europe Long-acting GLP-1RA Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 49. Japan Long-acting GLP-1RA Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 50. China Long-acting GLP-1RA Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 51. Novo Nordisk Long-acting GLP-1RA Basic Information
Table 52. Novo Nordisk Long-acting GLP-1RA Product Overview
Table 53. Novo Nordisk Long-acting GLP-1RA Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 54. Novo Nordisk Business Overview
Table 55. Novo Nordisk Long-acting GLP-1RA SWOT Analysis
Table 56. Novo Nordisk Recent Developments
Table 57. GSK Long-acting GLP-1RA Basic Information
Table 58. GSK Long-acting GLP-1RA Product Overview
Table 59. GSK Long-acting GLP-1RA Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 60. GSK Business Overview
Table 61. GSK Long-acting GLP-1RA SWOT Analysis
Table 62. GSK Recent Developments
Table 63. Novo Nordisk Long-acting GLP-1RA Basic Information
Table 64. Novo Nordisk Long-acting GLP-1RA Product Overview
Table 65. Novo Nordisk Long-acting GLP-1RA Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 66. Novo Nordisk Long-acting GLP-1RA SWOT Analysis
Table 67. Novo Nordisk Business Overview
Table 68. Novo Nordisk Recent Developments
Table 69. AstraZeneca Long-acting GLP-1RA Basic Information
Table 70. AstraZeneca Long-acting GLP-1RA Product Overview
Table 71. AstraZeneca Long-acting GLP-1RA Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 72. AstraZeneca Business Overview
Table 73. AstraZeneca Recent Developments
Table 74. Eli Lily Long-acting GLP-1RA Basic Information
Table 75. Eli Lily Long-acting GLP-1RA Product Overview
Table 76. Eli Lily Long-acting GLP-1RA Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 77. Eli Lily Business Overview
Table 78. Eli Lily Recent Developments
Table 79. Hansoh Pharmaceutical Long-acting GLP-1RA Basic Information
Table 80. Hansoh Pharmaceutical Long-acting GLP-1RA Product Overview
Table 81. Hansoh Pharmaceutical Long-acting GLP-1RA Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 82. Hansoh Pharmaceutical Business Overview
Table 83. Hansoh Pharmaceutical Recent Developments
Table 84. Global Long-acting GLP-1RA Sales Forecast by Region (2025-2032) & (K MT)
Table 85. Global Long-acting GLP-1RA Market Size Forecast by Region (2025-2032) & (M USD)
Table 86. North America Long-acting GLP-1RA Sales Forecast by Country (2025-2032) & (K MT)
Table 87. North America Long-acting GLP-1RA Market Size Forecast by Country (2025-2032) & (M USD)
Table 88. Europe Long-acting GLP-1RA Sales Forecast by Country (2025-2032) & (K MT)
Table 89. Europe Long-acting GLP-1RA Market Size Forecast by Country (2025-2032) & (M USD)
Table 90. Asia Pacific Long-acting GLP-1RA Sales Forecast by Region (2025-2032) & (K MT)
Table 91. Asia Pacific Long-acting GLP-1RA Market Size Forecast by Region (2025-2032) & (M USD)
Table 92. South America Long-acting GLP-1RA Sales Forecast by Country (2025-2032) & (K MT)
Table 93. South America Long-acting GLP-1RA Market Size Forecast by Country (2025-2032) & (M USD)
Table 94. Middle East and Africa Long-acting GLP-1RA Consumption Forecast by Country (2025-2032) & (Units)
Table 95. Middle East and Africa Long-acting GLP-1RA Market Size Forecast by Country (2025-2032) & (M USD)
Table 96. Global Long-acting GLP-1RA Sales Forecast by Type (2025-2032) & (K MT)
Table 97. Global Long-acting GLP-1RA Market Size Forecast by Type (2025-2032) & (M USD)
Table 98. Global Long-acting GLP-1RA Price Forecast by Type (2025-2032) & (USD/MT)
Table 99. Global Long-acting GLP-1RA Sales (K MT) Forecast by Application (2025-2032)
Table 100. Global Long-acting GLP-1RA Market Size Forecast by Application (2025-2032) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Long-acting GLP-1RA
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Long-acting GLP-1RA Market Size (M USD), 2019-2032
Figure 5. Global Long-acting GLP-1RA Market Size (M USD) (2019-2032)
Figure 6. Global Long-acting GLP-1RA Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Long-acting GLP-1RA Market Size by Country (M USD)
Figure 11. Long-acting GLP-1RA Sales Share by Manufacturers in 2023
Figure 12. Global Long-acting GLP-1RA Revenue Share by Manufacturers in 2023
Figure 13. Long-acting GLP-1RA Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Long-acting GLP-1RA Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Long-acting GLP-1RA Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Long-acting GLP-1RA Market Share by Type
Figure 18. Sales Market Share of Long-acting GLP-1RA by Type (2019-2024)
Figure 19. Sales Market Share of Long-acting GLP-1RA by Type in 2023
Figure 20. Market Size Share of Long-acting GLP-1RA by Type (2019-2024)
Figure 21. Market Size Market Share of Long-acting GLP-1RA by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Long-acting GLP-1RA Market Share by Application
Figure 24. Global Long-acting GLP-1RA Sales Market Share by Application (2019-2024)
Figure 25. Global Long-acting GLP-1RA Sales Market Share by Application in 2023
Figure 26. Global Long-acting GLP-1RA Market Share by Application (2019-2024)
Figure 27. Global Long-acting GLP-1RA Market Share by Application in 2023
Figure 28. Global Long-acting GLP-1RA Sales Growth Rate by Application (2019-2024)
Figure 29. Global Long-acting GLP-1RA Sales Market Share by Region (2019-2024)
Figure 30. North America Long-acting GLP-1RA Sales and Growth Rate (2019-2024) & (K MT)
Figure 31. North America Long-acting GLP-1RA Sales Market Share by Country in 2023
Figure 32. U.S. Long-acting GLP-1RA Sales and Growth Rate (2019-2024) & (K MT)
Figure 33. Canada Long-acting GLP-1RA Sales (K MT) and Growth Rate (2019-2024)
Figure 34. Mexico Long-acting GLP-1RA Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Long-acting GLP-1RA Sales and Growth Rate (2019-2024) & (K MT)
Figure 36. Europe Long-acting GLP-1RA Sales Market Share by Country in 2023
Figure 37. Germany Long-acting GLP-1RA Sales and Growth Rate (2019-2024) & (K MT)
Figure 38. France Long-acting GLP-1RA Sales and Growth Rate (2019-2024) & (K MT)
Figure 39. U.K. Long-acting GLP-1RA Sales and Growth Rate (2019-2024) & (K MT)
Figure 40. Italy Long-acting GLP-1RA Sales and Growth Rate (2019-2024) & (K MT)
Figure 41. Russia Long-acting GLP-1RA Sales and Growth Rate (2019-2024) & (K MT)
Figure 42. Asia Pacific Long-acting GLP-1RA Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Long-acting GLP-1RA Sales Market Share by Region in 2023
Figure 44. China Long-acting GLP-1RA Sales and Growth Rate (2019-2024) & (K MT)
Figure 45. Japan Long-acting GLP-1RA Sales and Growth Rate (2019-2024) & (K MT)
Figure 46. South Korea Long-acting GLP-1RA Sales and Growth Rate (2019-2024) & (K MT)
Figure 47. India Long-acting GLP-1RA Sales and Growth Rate (2019-2024) & (K MT)
Figure 48. Southeast Asia Long-acting GLP-1RA Sales and Growth Rate (2019-2024) & (K MT)
Figure 49. South America Long-acting GLP-1RA Sales and Growth Rate (K MT)
Figure 50. South America Long-acting GLP-1RA Sales Market Share by Country in 2023
Figure 51. Brazil Long-acting GLP-1RA Sales and Growth Rate (2019-2024) & (K MT)
Figure 52. Argentina Long-acting GLP-1RA Sales and Growth Rate (2019-2024) & (K MT)
Figure 53. Columbia Long-acting GLP-1RA Sales and Growth Rate (2019-2024) & (K MT)
Figure 54. Middle East and Africa Long-acting GLP-1RA Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Long-acting GLP-1RA Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Long-acting GLP-1RA Sales and Growth Rate (2019-2024) & (K MT)
Figure 57. UAE Long-acting GLP-1RA Sales and Growth Rate (2019-2024) & (K MT)
Figure 58. Egypt Long-acting GLP-1RA Sales and Growth Rate (2019-2024) & (K MT)
Figure 59. Nigeria Long-acting GLP-1RA Sales and Growth Rate (2019-2024) & (K MT)
Figure 60. South Africa Long-acting GLP-1RA Sales and Growth Rate (2019-2024) & (K MT)
Figure 61. Global Long-acting GLP-1RA Production Market Share by Region (2019-2024)
Figure 62. North America Long-acting GLP-1RA Production (K MT) Growth Rate (2019-2024)
Figure 63. Europe Long-acting GLP-1RA Production (K MT) Growth Rate (2019-2024)
Figure 64. Japan Long-acting GLP-1RA Production (K MT) Growth Rate (2019-2024)
Figure 65. China Long-acting GLP-1RA Production (K MT) Growth Rate (2019-2024)
Figure 66. Global Long-acting GLP-1RA Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Long-acting GLP-1RA Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Long-acting GLP-1RA Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Long-acting GLP-1RA Market Share Forecast by Type (2025-2032)
Figure 70. Global Long-acting GLP-1RA Sales Forecast by Application (2025-2032)
Figure 71. Global Long-acting GLP-1RA Market Share Forecast by Application (2025-2032)
Figure 1. Product Picture of Long-acting GLP-1RA
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Long-acting GLP-1RA Market Size (M USD), 2019-2032
Figure 5. Global Long-acting GLP-1RA Market Size (M USD) (2019-2032)
Figure 6. Global Long-acting GLP-1RA Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Long-acting GLP-1RA Market Size by Country (M USD)
Figure 11. Long-acting GLP-1RA Sales Share by Manufacturers in 2023
Figure 12. Global Long-acting GLP-1RA Revenue Share by Manufacturers in 2023
Figure 13. Long-acting GLP-1RA Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Long-acting GLP-1RA Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Long-acting GLP-1RA Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Long-acting GLP-1RA Market Share by Type
Figure 18. Sales Market Share of Long-acting GLP-1RA by Type (2019-2024)
Figure 19. Sales Market Share of Long-acting GLP-1RA by Type in 2023
Figure 20. Market Size Share of Long-acting GLP-1RA by Type (2019-2024)
Figure 21. Market Size Market Share of Long-acting GLP-1RA by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Long-acting GLP-1RA Market Share by Application
Figure 24. Global Long-acting GLP-1RA Sales Market Share by Application (2019-2024)
Figure 25. Global Long-acting GLP-1RA Sales Market Share by Application in 2023
Figure 26. Global Long-acting GLP-1RA Market Share by Application (2019-2024)
Figure 27. Global Long-acting GLP-1RA Market Share by Application in 2023
Figure 28. Global Long-acting GLP-1RA Sales Growth Rate by Application (2019-2024)
Figure 29. Global Long-acting GLP-1RA Sales Market Share by Region (2019-2024)
Figure 30. North America Long-acting GLP-1RA Sales and Growth Rate (2019-2024) & (K MT)
Figure 31. North America Long-acting GLP-1RA Sales Market Share by Country in 2023
Figure 32. U.S. Long-acting GLP-1RA Sales and Growth Rate (2019-2024) & (K MT)
Figure 33. Canada Long-acting GLP-1RA Sales (K MT) and Growth Rate (2019-2024)
Figure 34. Mexico Long-acting GLP-1RA Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Long-acting GLP-1RA Sales and Growth Rate (2019-2024) & (K MT)
Figure 36. Europe Long-acting GLP-1RA Sales Market Share by Country in 2023
Figure 37. Germany Long-acting GLP-1RA Sales and Growth Rate (2019-2024) & (K MT)
Figure 38. France Long-acting GLP-1RA Sales and Growth Rate (2019-2024) & (K MT)
Figure 39. U.K. Long-acting GLP-1RA Sales and Growth Rate (2019-2024) & (K MT)
Figure 40. Italy Long-acting GLP-1RA Sales and Growth Rate (2019-2024) & (K MT)
Figure 41. Russia Long-acting GLP-1RA Sales and Growth Rate (2019-2024) & (K MT)
Figure 42. Asia Pacific Long-acting GLP-1RA Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Long-acting GLP-1RA Sales Market Share by Region in 2023
Figure 44. China Long-acting GLP-1RA Sales and Growth Rate (2019-2024) & (K MT)
Figure 45. Japan Long-acting GLP-1RA Sales and Growth Rate (2019-2024) & (K MT)
Figure 46. South Korea Long-acting GLP-1RA Sales and Growth Rate (2019-2024) & (K MT)
Figure 47. India Long-acting GLP-1RA Sales and Growth Rate (2019-2024) & (K MT)
Figure 48. Southeast Asia Long-acting GLP-1RA Sales and Growth Rate (2019-2024) & (K MT)
Figure 49. South America Long-acting GLP-1RA Sales and Growth Rate (K MT)
Figure 50. South America Long-acting GLP-1RA Sales Market Share by Country in 2023
Figure 51. Brazil Long-acting GLP-1RA Sales and Growth Rate (2019-2024) & (K MT)
Figure 52. Argentina Long-acting GLP-1RA Sales and Growth Rate (2019-2024) & (K MT)
Figure 53. Columbia Long-acting GLP-1RA Sales and Growth Rate (2019-2024) & (K MT)
Figure 54. Middle East and Africa Long-acting GLP-1RA Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Long-acting GLP-1RA Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Long-acting GLP-1RA Sales and Growth Rate (2019-2024) & (K MT)
Figure 57. UAE Long-acting GLP-1RA Sales and Growth Rate (2019-2024) & (K MT)
Figure 58. Egypt Long-acting GLP-1RA Sales and Growth Rate (2019-2024) & (K MT)
Figure 59. Nigeria Long-acting GLP-1RA Sales and Growth Rate (2019-2024) & (K MT)
Figure 60. South Africa Long-acting GLP-1RA Sales and Growth Rate (2019-2024) & (K MT)
Figure 61. Global Long-acting GLP-1RA Production Market Share by Region (2019-2024)
Figure 62. North America Long-acting GLP-1RA Production (K MT) Growth Rate (2019-2024)
Figure 63. Europe Long-acting GLP-1RA Production (K MT) Growth Rate (2019-2024)
Figure 64. Japan Long-acting GLP-1RA Production (K MT) Growth Rate (2019-2024)
Figure 65. China Long-acting GLP-1RA Production (K MT) Growth Rate (2019-2024)
Figure 66. Global Long-acting GLP-1RA Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Long-acting GLP-1RA Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Long-acting GLP-1RA Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Long-acting GLP-1RA Market Share Forecast by Type (2025-2032)
Figure 70. Global Long-acting GLP-1RA Sales Forecast by Application (2025-2032)
Figure 71. Global Long-acting GLP-1RA Market Share Forecast by Application (2025-2032)
